{"groups":[{"description":"Oxaliplatin + Leucovorin + 5-Fluorouracil","id":"FG000","title":"Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil"},{"description":"Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab","id":"FG001","title":"Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"18"}],"type":"No follow-up data"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"}],"type":"Patient not at risk for primary endpoint"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1356"},{"groupId":"FG001","numSubjects":"1354"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1338"},{"groupId":"FG001","numSubjects":"1334"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"20"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}